scientifyRESEARCH
research funding database

RESEARCH FUNDING

This opportunity is currently closed.

Sign up for Content alerts to stay informed when this or related funding opportunities are posted.

Early-Stage ALS Clinicians (worldwide)

Share this post

Logo of scientifyRESEARCH and Enago "Author First, Quality First" scientifyRESEARCH recommends English editing and author support services from Enago.
Logo of scientifyRESEARCH + logo of Enago "Author First, Quality First" scientifyRESEARCH recommends English editing and author support services from Enago.

The Early-Stage ALS Clinicians from Target ALS Foundation supports talent early-career clinician scientists working on Amyotrophic Lateral Sclerosis (ALS). Target ALS is especially interested in proposals that address or incorporate the following topics:

  • Identification, validation and development of new ALS biomarkers and diagnostic criteria
  • Understanding clinical contributions from FTD
  • Data-driven examination of multimodal biomarkers for the definition of prognosis
  • Prospective-retrospective biomarker integration to evaluate clinical outcomes
  • Risk and stratification models for clinical trial inclusion
  • Clinical outcome measures
  • Therapeutic targets
  • Tools and technologies to facilitate human proof-of-biology studies

Applicants should hold an MD or equivalent degree and be an early-stage ALS clinician or clinician scientist who received their clinical appointment on or after August 14, 2018. The award provides 150,000 USD/year for up to 3 years, including 15% indirect costs.

Applications are due September 28, 2023.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for our monthly
research funding newsletter

you can unsubscribe at any time

Be the first to know

Sign-up for Personalized Grant Alerts

Logo3